AMEX · ITDF
iShares LifePath Target Date 2050 ETF
$41.10-$0.60 (-1.44%)
iShares LifePath Target Date 2050 ETF’s quoted price sits in the upper half of its reported 52-week range, 4.31% below the high.
Loading market information…
NASDAQ · IBBQ · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Invesco Nasdaq Biotechnology ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Invesco Nasdaq Biotechnology ETF’s forward annual dividend is $0.92 per share, paid quarterly. The forward yield is 2.55% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The Invesco Nasdaq Biotechnology ETF (IBBQ) seeks to mirror the investment performance of the Nasdaq Biotechnology Index. To achieve this, the Fund generally dedicates at least 90% of its total capital to the securities that make up this benchmark index. The underlying Index itself is specifically designed to gauge the returns of biotechnology and pharmaceutical companies whose shares are publicly traded on the Nasdaq Stock Market. Both the ETF and its corresponding Index undergo a yearly review and update of their composition each December, and their weightings are adjusted quarterly in March, June, September, and December.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 04:43 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$41.10-$0.60 (-1.44%)
iShares LifePath Target Date 2050 ETF’s quoted price sits in the upper half of its reported 52-week range, 4.31% below the high.
$39.70-$0.49 (-1.23%)
iShares LifePath Target Date 2045 ETF’s quoted price sits in the upper half of its reported 52-week range, 3.71% below the high.
$99.61+$1.08 (+1.09%)
First Trust RiverFront Dynamic Emerging Markets ETF’s quoted price sits in the upper half of its reported 52-week range, 1.21% below the high.
$69.60-$2.81 (-3.88%)
Pacer US Export Leaders ETF’s quoted price sits in the upper half of its reported 52-week range, 8.23% below the high.
$39.41-$0.23 (-0.58%)
Touchstone Dividend Select ETF’s quoted price sits in the upper half of its reported 52-week range, 1.77% below the high.
$180.91-$12.30 (-6.37%)
Invesco Next Gen Connectivity ETF’s quoted price sits in the upper half of its reported 52-week range, 17.7% below the high.
$63.71-$0.28 (-0.44%)
AXS Knowledge Leaders ETF’s quoted price sits in the upper half of its reported 52-week range, 2.35% below the high.
$35.65+$0.56 (+1.6%)
Invesco S&P SmallCap Consumer Staples ETF’s quoted price sits in the upper half of its reported 52-week range, 6.72% below the high.
